HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pereira, L. E. Articles by Ansari, A. A. Search for Related Content PubMed PubMed Citation Articles by Pereira, L. E. Articles by Ansari, A. A.

---

ORIGINAL RESEARCH ARTICLE

Pharmacokinetics, Toxicity, and Functional Studies of the Selective Kv1.3 Channel Blocker 5-(4-Phenoxybutoxy)Psoralen in Rhesus Macaques

L. E. Pereira^*, F. Villinger^*, H. Wulff, A. Sankaranarayanan, G. Raman and A. A. Ansari^*,1

^* Department of Pathology & Lab Medicine, Emory University School of Medicine, Atlanta, Georgia 30322; and Department of Medical Pharmacology, University of California–Davis, Genome & Biomedical Sciences Facility, Davis, California 95616

To whom requests for reprints should be addressed at ¹ 101 Woodruff Circle, Room 2309, Department of Pathology and Lab Medicine, Emory University, Atlanta, GA 30322; E-mail: pathaaa{at}emory.edu

The small molecule 5-(4-phenoxybutoxy)psoralen (PAP-1) is a selective blocker of the voltage-gated potassium channel Kv1.3 that is highly expressed in cell membranes of activated effector memory T cells (TEMs). The blockade of Kv1.3 results in membrane depolarization and inhibition of TEM proliferation and function. In this study, the in vitro effects of PAP-1 on T cells and the in vivo toxicity and pharmacokinetics (PK) were examined in rhesus macaques (RM) with the ultimate aim of utilizing PAP-1 to define the role of TEMs in RM infected with simian immunodeficiency virus (SIV). Electrophysiologic studies on T cells in RM revealed a Kv1.3 expression pattern similar to that in human T cells. Thus, PAP-1 effectively suppressed TEM proliferation in RM. When administered intravenously, PAP-1 showed a half-life of 6.4 hrs; the volume of distribution suggested extensive distribution into extravascular compartments. When orally administered, PAP-1 was efficiently absorbed. Plasma concentrations in RM undergoing a 30-day, chronic dosing study indicated that PAP-1 levels suppressive to TEMs in vitro can be achieved and maintained in vivo at a non-toxic dose. PAP-1 selectively inhibited the TEM function in vivo, as indicated by a modest reactivation of cytomegalovirus (CMV) replication. Immunization of these chronically treated RM with the live influenza A/PR8 (flu) virus suggested that the development of an in vivo, flu-specific, central memory response was unaffected by PAP-1. These RM remained disease-free during the entire course of the PAP-1 study. Collectively, these data provide a rational basis for future studies with PAP-1 in SIV-infected RM.

Key Words: effector memory T-cells • SIV • PAP-1 • K+ channel blockers

This article has been cited by other articles:

				M. W. Pennington, C. Beeton, C. A. Galea, B. J. Smith, V. Chi, K. P. Monaghan, A. Garcia, S. Rangaraju, A. Giuffrida, D. Plank, et al. Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes Mol. Pharmacol., April 1, 2009; 75(4): 762 - 773. [Abstract] [Full Text] [PDF]

				R. Larbat, A. Hehn, J. Hans, S. Schneider, H. Jugde, B. Schneider, U. Matern, and F. Bourgaud Isolation and Functional Characterization of CYP71AJ4 Encoding for the First P450 Monooxygenase of Angular Furanocoumarin Biosynthesis J. Biol. Chem., February 20, 2009; 284(8): 4776 - 4785. [Abstract] [Full Text] [PDF]